Valuation GlaxoSmithKline Pharmaceuticals Limited NSE India S.E.

Stocks

Market Closed - NSE India S.E. Other stock markets 07:05:08 2026-07-10 am EDT			5-day change	1st Jan Change
2,438.20 ^INR	-0.09%		+1.78%	-1.43%

May. 29	GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Dr. Simrat Sohal from Compliance Officer and Ceases to Be the Senior Management Personnel, Effective August 5, 2026	CI
May. 13	GlaxoSmithKline Pharmaceuticals Clocks Higher Fiscal Q4 Consolidated Net Profit	MT

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	281,714	224,319	329,173	487,432	386,822	412,588	-
Change	-	-20.37%	46.74%	48.08%	-20.64%	6.66%	-
Enterprise Value (EV)	256,351	207,663	329,173	487,432	386,822	412,588	412,588
Change	-	-18.99%	58.51%	48.08%	-20.64%	6.66%	0%
P/E	16.6x	36.7x	55.8x	52.5x	37.3x	35.8x	31.5x
PBR	10.6x	12.9x	18.5x	25x	17.1x	15.5x	13.2x
PEG	-	-0.6x	-16.49x	0.9x	3.2x	3.2x	2.3x
Capitalization / Revenue	8.59x	6.9x	9.53x	13x	10.1x	9.84x	8.88x
EV / Revenue	0x	0x	0x	0x	0x	9.84x	8.88x
EV / EBITDA	0x	0x	0x	0x	0x	28.1x	24.7x
EV / EBIT	0x	0x	0x	0x	0x	30x	26.2x
EV / FCF	0x	0x	0x	0x	0x	35.6x	32.1x
FCF Yield	2.75%	1.96%	1.67%	2.6%	2.19%	2.81%	3.11%
Dividend per Share ²	30	32	32	42	57	29.5	29.5
Rate of return	1.8%	2.42%	1.65%	1.46%	2.5%	1.21%	1.21%
EPS ²	100	36.05	34.83	54.76	61.15	67.98	77.28
Distribution rate	30%	88.8%	91.9%	76.7%	93.2%	43.4%	38.2%
Net sales ¹	32,780	32,517	34,537	37,492	38,217	41,939	46,453
EBITDA ¹	8,273	8,043	9,087	11,774	13,092	14,683	16,675
EBIT ¹	7,592	7,385	8,390	11,106	12,428	13,760	15,728
Net income ¹	16,947	6,107	5,900	9,276	10,360	11,515	12,873
Net Debt	-25,363	-16,656	-	-	-	-	-
Reference price ²	1,662.95	1,324.15	1,943.10	2,877.30	2,283.40	2,435.50	2,435.50
Nbr of stocks (in thousands)	169,406	169,406	169,406	169,406	169,406	169,406	-
Announcement Date	5/16/22	5/17/23	5/17/24	5/13/25	5/13/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ELI LILLY AND COMPANY	34.92x	12.63x	25.81x	0.57%	1,060B
JOHNSON & JOHNSON	27.42x	6.3x	17.1x	2.08%	619B
ABBVIE INC.	30x	7.34x	15.02x	2.76%	438B
ROCHE HOLDING AG	17.98x	4.45x	11.01x	2.97%	333B
NOVARTIS AG	21.52x	5.52x	13.36x	2.86%	282B
ASTRAZENECA PLC	21.56x	4.53x	12.65x	1.94%	267B
NOVO NORDISK A/S	14.17x	5.3x	10.9x	3.52%	218B
AMGEN INC.	23.77x	6.31x	11.12x	2.78%	196B
GILEAD SCIENCES, INC.	-46.02x	5.6x	31.12x	2.5%	161B
Average	16.15x	6.44x	16.46x	2.44%	397.1B
Weighted average by Cap.	23.86x	7.85x	18.16x	2%